Hint: Code 93978 is for a complete study. In the article “Ankle-Brachial Index Instrumental for Diagnosing Peripheral Artery Disease,” in Cardiology Coding Alert Volume 27, Issue 7, you learned all about ABIs, including the codes you would report and the guidelines you should follow. Now, see what Elizabeth Herbert, RHIA, CPC, CDEO, CPMA, CRC, CCC, AAPC Approved Instructor, had to say about the additional imaging that may be necessary before peripheral artery disease (PAD) intervention, in her HEALTHCON 2024 session “Peripheral Artery Disease: Diagnostics and Treatments of the Lower Extremities.” Read on to learn about three different types of imaging you may see in the documentation for PAD. Type 1: Duplex Ultrasonography is Non-Invasive Test One option for imaging is duplex ultrasonography, which evaluates the status of a patient’s vascular disease and provides information about hemodynamics, Herbert said. It’s non-invasive, doesn’t need contrast material, and is more readily available but highly technician-dependent. Duplex ultrasonography is typically obtained for a more focused evaluation of localization of stenosis or to check stent or bypass graft patency, Hebert added.
The arterial duplex ultrasound codes you may see are as follows: Type 2: Focus on CTA Computed Tomography Angiography (CTA) is considered to be highly specific and sensitive when evaluating PAD, Herbert said. “They are great for evaluation of inflow disease or assessment of graft patency. They are relatively inexpensive and quick but with disadvantages of IV [intravenous] contrast use and radiation exposure.” CTA codes you may see include the following: Don’t miss: The Centers for Medicare & Medicaid Services (CMS) established MUE as a unit-of-service edit for HCPCS Level II/ CPT® codes. An MUE is assigned to a specific code to represent the maximum number of units of the code that you should report — either on a specific claim or on a specific date. CMS developed the edits to reduce the paid claims error rate for Medicare claims. Exceptions: For instance, when a provider legitimately exceeds the MUE frequency limit, Medicare has provided guidance for how to override an MUE value, using “distinct service” modifiers, such as 59 (Distinct procedural service) or the X{EPSU} modifiers. Alert: The MUE table includes a column for “MUE Adjudication Indicator” (MAI), which provides guidance about what circumstances allow you to override an MUE limit for a given code. If the code has an MAI of “1,” the code is adjudicated on a claim-line basis, meaning that you can’t exceed the number of MUE units on a claim line. You are allowed to use one of the distinct service modifiers to override the edit if circumstances allow. An MAI of “2” means that the frequency limit is absolute for a date of service, and you may not override the edit with a modifier.
Type 3: Rely on 72198, 73725, 73725 for MRA Magnetic Resonance Angiography (MRA) is comparable to CTA for evaluation of inflow disease and bypass graft patency but may be limited and give suboptimal assessment of stents due to artifact, Herbert said. MRAs are more time-consuming and costly than CTAs. The use could be contraindicated for some patients with implanted devices, and there may be a risk of nephrogenic systemic fibrosis from gadolinium in stage 4-5 chronic kidney disease (CKD) patients. MRA codes you may see include the following: